Weed (BUDZ) Return on Capital Employed (2011 - 2026)
Weed (BUDZ) posted quarterly Return on Capital Employed of 128.98% for Q1 2026, down 17327.0% year-over-year from N/an in Q1 2025, and down 31.52% quarter-over-quarter from 188.35% in Q4 2025.
Weed (BUDZ) Return on Capital Employed (2011 - 2026) Analysis & Trends
Weed's Return on Capital Employed history runs 11 years deep, the most recent figure standing at 128.98% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 17327.0% year-over-year to 128.98%; the TTM figure through Mar 2026 stood at 128.98% (down 17327.0% YoY), while the FY2025 annual figure was 221.6%, down 16201.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 128.98%, down from 188.35% in the prior quarter.
- The five-year high for Return on Capital Employed was 980.82% in Q2 2023, with the low at 1010.89% in Q2 2024.
- The 5-year median for Return on Capital Employed is 136.02% (2023), against an average of 66.84%.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed tumbled 199171 bps in 2024, then jumped 118312 bps in 2025.
- Weed's Return on Capital Employed stood at 262.12% in 2022, then soared by 47 bps to 138.63% in 2023, then soared by 232 bps to 182.52% in 2024, then climbed by 3 bps to 188.35% in 2025, then slumped by 32 bps to 128.98% in 2026.
- Business Quant data shows BUDZ's Return on Capital Employed at 128.98% in Q1 2026, 188.35% in Q4 2025, and 141.58% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Weed | 3.13 Mn | 3.13 Mn | - | 112.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128.98% |
| Dec 31, 2025 | 188.35% |
| Sep 30, 2025 | 141.58% |
| Jun 30, 2025 | 172.23% |
| Mar 31, 2025 | 302.25% |
| Dec 31, 2024 | 182.52% |
| Sep 30, 2024 | 515.18% |
| Jun 30, 2024 | -1,010.89% |
| Mar 31, 2024 | -286.71% |
| Dec 31, 2023 | -138.63% |
| Sep 30, 2023 | -136.02% |
| Jun 30, 2023 | 980.82% |
| Mar 31, 2023 | -967.60% |
| Dec 31, 2022 | -262.12% |
| Sep 30, 2022 | -144.42% |
| Jun 30, 2022 | -196.05% |
| Mar 31, 2022 | -605.82% |
| Dec 31, 2021 | -514.20% |
| Sep 30, 2021 | -311.30% |
| Jun 30, 2021 | -292.12% |